SecBot SecBot
SECBOTREPLAY Home › Report › VTGN

VTGN · Vistagen Therapeutics granted stock options to purchase 75,000 shares…

Vistagen Therapeutics, Inc. · 8-K filed Apr 13, 2026 at 17:27 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Apr 13, 2026 at 17:27 ET

Vistagen Therapeutics granted stock options to purchase 75,000 shares each to its CEO and other executive officers as retention awards. The options vest over two years and are intended to incentivize key leadership.

  • Retention stock options granted to CEO Shawn K. Singh and four other executive officers.
  • Each executive received options to purchase 75,000 shares of common stock.
  • Options have an exercise price of $0.5358 per share and vest 25% every six months over two years.
  • Awards were approved by the Compensation Committee on April 7, 2026, under the 2019 Omnibus Equity Incentive Plan.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access